Fig. 5From: Development of an immune-related gene prognostic risk model and identification of an immune infiltration signature in the tumor microenvironment of colon cancerValidation of the prognostic risk model. a Overall survival (OS) in the validation cohort. b Time-dependent receiver operating characteristic (ROC) curve analysis (b-1:ROC 1Â year, b-2:ROC 3Â year, b-3:ROC 5Â year) in the validation cohort. c Risk score distribution plot in the validation cohort. d Survival status scatter plots in the validation cohortBack to article page